Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Cerebrovascular Stroke" wg kryterium: Temat


Wyświetlanie 1-4 z 4
Tytuł:
The effectiveness of patent foramen ovale closure and antiplatelet or anticoagulant therapies for cryptogenic ischemic stroke
Autorzy:
Marciniec, Michał
Szczepańska-Szerej, Anna
Kulczyński, Marcin
Popek-Marciniec, Sylwia
Pasterczyk, Katarzyna
Rejdak, Konrad
Powiązania:
https://bibliotekanauki.pl/articles/1177466.pdf
Data publikacji:
2018
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
Anticoagulation Agents
Antiplatelet Agents
Cerebral Infarction
Cerebrovascular Stroke
Patent Foramen Ovale
Opis:
Patent foramen ovale (PFO) occurs in approximately 50% cryptogenic strokes cases. One of the most clinically important consequences of PFO is paradoxical embolization of venous thrombus resulting in recurrent stroke. The aim of this meta-analysis is to compare the efficacy and safety of PFO closure and antiplatelet or anticoagulant therapy alone (medical therapy, MT) in the secondary stroke prevention. Eligible studies for meta-analysis published from May 2008 to May 2018 were identified through a search of PubMed database and two clinical trial registries websites: ClinicalTrials.gov and EU Clinical Trials Register. A meta-analysis was conducted with the use of Statistica software version 13.1. Three studies comprising 2’307 patients were included. The main outcomes were: recurrent stroke occurrence during follow-up period, the frequency of serious adverse events (SAE) and the mortality rate. Statistical significance was found in the assessment of recurrent stroke occurrence when the comparison referred to PFO closure and antiplatelet therapy (RR 0,30, p < 0,05, 95% CI 0,11 – 0,85). There were no significant differences between PFO closure and MT in the frequency of SAE occurrence (RR 1,03, p = 0,73) and mortality rates (RR 0,69, p = 0,39). Current clinical data indicate that PFO closure devices applied to the carefully selected group of young and middle-aged patients with cryptogenic ischemic stroke may be as or more effective than antiplatelet therapy.
Źródło:
World Scientific News; 2018, 102; 47-58
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Investigating the severity and factors influencing the occurrence of pressure ulcers in hospitalized cerebrovascular accident patients: a retrospective cohort study
Autorzy:
Fallahi, Masoud
Vafaee, Kamran
Korab, Maciej
Sadeghi, Narges
Moradi, Yasaman
Amini, Mahin
Karimi, Zohreh
Mahdavikian, Somayeh
Powiązania:
https://bibliotekanauki.pl/articles/29519599.pdf
Data publikacji:
2024-02-23
Wydawca:
Fundacja Edukacji Medycznej, Promocji Zdrowia, Sztuki i Kultury Ars Medica
Tematy:
pressure ulcers
cerebrovascular accidents
stroke
cohort study
Opis:
Patients with cerebrovascular accidents (CVA) are at risk of developing PUs due to sensory, motor and cognitive deficits following the disease. Therefore, the aim of the present study was to investigate the severity and factors affecting the occurrence of PUs in patients with CVA. The present study was a retrospective cohort study. The data of this research was extracted from the registry system of Imam Reza Hospital located in the west of Iran. 217 patients with CVA with Braden score below 14 or with PU were included in the study. In order to investigate the relationship between independent variables and wound stage in univariate regression model, logistic regression was used, and the results were reported as odds ratio (OR). Data were analyzed with Stata statistical software version 15 and Excel 2016 software. Out of 217 CVA patients hospitalized, 180 had pressure ulcers. In total, 465 PUs were diagnosed in 180 patients in different areas. The average age of patients was (SD=61±8.78) years. 65 patients suffered only one wound, 38 patients experienced two wounds, and 37 patients experienced three wounds. The highest number of PUs was with 201 cases of stage I, followed by 180 cases of stage II. Stage IV with 2 cases was the least PU cases. Patients with a Braden score of 10-12 were 3.89 times more likely than patients with a Braden score greater than 14, and patients with a Braden score of 6-9 were diagnosed with PUS 6.67 times more than those with a Braden score greater than 14. Regarding the site of PUs, the sacrum and then the buttock were the most common sites of PU, which were observed in 65.56% and 29.49% of patients, respectively. The highest number of stage I was related to the sacrum area. The sacrum was the most common site of PU occurrence and the highest number of PUs was related to stage I. Age, fecal incontinence, hemoglobin levels and Braden’s score have been among the factors affecting PUs in patients with CVA.
Źródło:
Acta Neuropsychologica; 2024, 22(1); 67-80
1730-7503
2084-4298
Pojawia się w:
Acta Neuropsychologica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Trends in premature cerebrovascular disease mortality in the Polish population aged 25-64 years, 2000-2016
Autorzy:
Cicha-Mikolajczyk, A.
Piwonska, A.
Smigielski, W.
Drygas, W.
Powiązania:
https://bibliotekanauki.pl/articles/2083103.pdf
Data publikacji:
2022
Wydawca:
Narodowy Instytut Zdrowia Publicznego. Państwowy Zakład Higieny
Tematy:
cerebrovascular disease
stroke
premature mortality
Polska
mortality trend
choroby naczyn mozgowych
udar mozgu
umieralnosc
choroby czlowieka
Polska
Opis:
Background. Many scientific reports have shown a decrease in total cerebrovascular disease (CeVD) mortality over the past few decades, but too little attention has been paid to premature mortality. CeVD accounted for 22.5% and 17.8% of premature cardiovascular disease deaths in Poland, in 2000 and 2016, respectively. Objective. The aim of the study was to analyse premature CeVD mortality in the Polish population in the recent years, the dynamics of its changes and the potential factors that may have contributed to the decline in mortality. The main goal of the study was to overview the levels and trends in premature CeVD mortality with an emphasis on haemorrhagic, ischaemic and unspecified (not specified as haemorrhagic or ischaemic) stroke. Material and methods. The analysis was based on adatabase of the Central Statistical Office of Poland and included data from 2000-2016 on premature cerebrovascular deaths occurring between 25 and 64 years of age (N=104,786). CeVD and haemorrhagic, ischaemic or unspecified stroke were coded with ICD-10 codes I60-I69, I61-I62, I63 and I64, respectively. The analysis included assessment of CeVD deaths distribution and evaluation of age-specific mortality rates in 10-year age groups and age-standardised mortality rates (SMR) in the age group 25-64 years, separately for men and women. Trends in SMRs have been studied in the period 2000-2016. Results. The number of CeVD deaths decreased by 32.8% in men and 48.8% in women. There was a two-fold decline in CeVD mortality: from 59 to 29 male and from 30 to 12 female per 100,000. In addition, a 2-year increase in the median age of CeVD death was observed (Men: 56.4 to 58.4 years, Women: 56.4 to 58.7 years, p<0.001). A statistically significant decline in mortality (per 100,000) was also noticed for haemorrhagic stroke (Men: 18.7 to 10.4; Women: 9.6 to 3.8), ischaemic stroke (Men: 11.8 to 8.4; Women: 4.7 to 3.0) and unspecified stroke (Men: 19.7 to 3.5; Women: 9.1 to 1.3). Conclusions. A substantial decline in premature CeVD mortality was observed in the period 2000-2016. Additionally, the number of deaths that could not be classified as haemorrhagic or ischaemic stroke death decreased significantly. The increasingly widespread use of new post-stroke therapies and their availability make it possible to expect a further decrease in CeVD mortality. However, the necessary actions should be taken to compensate for the disparities in CeVD mortality between men and women.
Źródło:
Roczniki Państwowego Zakładu Higieny; 2022, 73, 1; 87-97
0035-7715
Pojawia się w:
Roczniki Państwowego Zakładu Higieny
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Występowanie leukoarajozy u pacjentów z udarem mózgu hospitalizowanych w oddziale udarowym
Leukoaraiosis in stroke patients hospitalized in stroke unit
Autorzy:
Rościszewska-Żukowska, Iwona
Kwolek, Andrzej
Kruk, Wacław
Cichocka, Izabela
Powiązania:
https://bibliotekanauki.pl/articles/437967.pdf
Data publikacji:
2013
Wydawca:
Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
Tematy:
udar mózgowy
udar niedokrwienny
udar krwotoczny
ostre zaburzenia krążenia mózgowego
zwyrodnienie istoty białej
choroba małych naczyń mózgowych
cerebral stroke
ischemic stroke
hemorrhagic stroke
cerebrovascular apoplexy
white matter changes
cerebral small vessel disease
Opis:
Cel: Celem pracy była ocena częstości występowania, obecności czynników ryzyka leukoarajozy oraz jej korelacjaz wielkością deficytu neurologicznego w populacji pacjentów z udarem mózgu. Materiał i metoda: Analizie poddano 100 pacjentów hospitalizowanych w oddziale udarowym Szpitala MSW w Rzeszowie z powodu udaru niedokrwiennego i udaru krwotocznego mózgu w okresie 01.10.2011 do 31.12.2011. Każdy pacjent miał wykonane badanie Tomografii Komputerowej, był oceniony neurologicznie za pomocą międzynarodowej skali udarowej NIHSS. Na podstawie autorskiego arkusza opracowano dane demograficzne, środowiskowe i kliniczne każdego pacjenta. Wyodrębniono grupę 41 osób (25 kobiet i 16 mężczyzn) ze zmianami istoty białej o typie leukoarajozy (LA), którą podzielono na dwie podgrupy: pacjenci z udarem niedokrwiennym i krwotocznym. W obrębie tej populacji oceniano obecność ognisk malacyjnych w mózgowiu oraz współistnienie dodatkowych chorób. Wyniki badań poddano analizie statystycznej. Wyniki: Średnia wieku pacjentów z udarem i leukoarajozą wyniosła 78,4 lat i była istotnie wyższa od wieku pacjentów z udarem bez zmian okołokomorowej istoty białej (72,7 lat). Leukoarajoza była obecna u 62% kobiet i 39% mężczyzn. Na podstawie testu chi kwadrat potwierdzono, iż płeć żeńska jest czynnikiem predysponującym do zmian istoty białej o typie LA. Zmiany malacyjne niedokrwienne częściej występowały u osób z leukoarajozą (51,3%) w porównaniu do grupy chorych z prawidłowym obrazem radiologicznym istoty białej (33%). Średni (10,0 pkt) oraz najwyższy (26 pkt) deficyt neurologiczny w grupie pacjentów z udarem i LA był niższy niż w grupie pacjentów bez zmian o typie leukoarajozy, gdzie odpowiednio wyniósł (12,0 pkt i 37 pkt). Najczęściej spotykanymi schorzeniami towarzyszącymi leukoarajozie były: nadciśnienie tętnicze (87,8%) oraz hipercholesterolemia (65,8%), które wystąpiły odpowiednio u 6,8% oraz 23,7% pacjentów z prawidłowym obrazem radiologicznym istoty białej. Pozostałe oceniane choroby: choroba wieńcowa serca, cukrzyca, niewydolność krążenia, zespół otępienny, niedoczynność i nadczynność tarczycy występowały częściej w grupie chorych bez patologicznych zmian w istocie białej. Wnioski: Płeć żeńska i wiek są istotnymi czynnikami ryzyka leukoarajozy. Częstość występowania LA w badanej populacji wyniosła 41%. Leukoarajoza predysponuje do udarów niedokrwiennych mózgu z niższym deficytem neurologicznym. U pacjentów ze zmianami okołokomorowej istoty białej przebyte naczyniopochodne ogniska malacyjne występują częściej. Hipercholesterolemia i nadciśnienie tętnicze są najczęstszymi chorobami współistniejącymi z leukoarajozą
Objective: The aim of the study was to assess the prevalence and risk factors for leukoaraiosis, and its correlation with the score of neurological impairment in the acute stroke patients population. Materials and methods: The analysis included 100 patients with ischemic and hemorrhagic stroke hospitalized in the stroke unit of the MSW Hospital in Rzeszow from 01.10.2011 to 31.12.2011. All the patients had a CT scans, were neurologically examined using the international stroke scale NIHSS. Demographic, environmental and clinical data of each patient were assessed using the author’s spreadsheet. A group of 41 people (25 women and 16 men) with white matter changes - leukoaraiosis (LA) was divided into two subgroups: patients with ischemic and hemorrhagic stroke. The presence of lacunar lesions and comorbidities was assessed in this population. The results were analyzed statistically. Results: The average age of patients with stroke and leukoaraiosis was 78.4 years of age and was significantly higher than the age of patients with stroke without periventricular white matter changes (72.7 years). Leukoaraiosis was present in 62% of women and 39% of men. Based on chi-square test it was confirmed that being a female is a factor predisposing to white matter changes - LA. Malacic ischemic lesions were more frequent in patients with leukoaraiosis (51.3%) comparing to the group of patients with normal CT scans of white matter (33%). The average and the highest scores of neurological deficit in patients with stroke and LA (respectively 10 and 26) were lower than in patients without white matter changes (scores respectively:12.0 and 37). The most common comorbidities associated with leukoaraiosis were hypertension (87.8%) and hypercholesterolemia (65.8%), which appeared respectively in 6.8% and 23.7% of patients with normal CT of white matter. The prevalence of other diseases like coronary heart disease, diabetes, circulatory insufficiency, dementia, hypothyreosis and hyperthyreosis were more frequent in patients without the pathological changes in white matter. Conclusions: Gender and age are important leukoaraiosis risk factors. The frequency of LA in the studied population was 41%. Leukoaraiosis predisposes to ischemic stroke with lower neurological deficit. Lacunar ischemic lesions are more frequent in patients with periventricular white matter changes. Hypercholesterolemia and hypertension are the most common comorbidities coexisting with leukoaraiosis
Źródło:
Medical Review; 2013, 3; 288-297
2450-6761
Pojawia się w:
Medical Review
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies